Your browser doesn't support javascript.
loading
[Torecan-induced neuroleptic malignant syndrome].
Bulvik, S; Shimoni, Z; Kaplan, C L.
Affiliation
  • Bulvik S; Dept. of Medicine B, Central Hospital of the Emek, Afula.
Harefuah ; 118(10): 576-8, 1990 May 15.
Article in He | MEDLINE | ID: mdl-2358219
ABSTRACT
Neuroleptic malignant syndrome (NMS) is an uncommon, life-threatening complication of treatment with neuroleptic drugs. Its main features are hyperthermia, extrapyramidal signs, and autonomic instability with fluctuating consciousness. It is believed that NMS is related to dopamine receptor blockade in the brain. We describe a case in a 52-year-old diabetic woman who developed NMS after taking Torecan (thiethylperazine), a phenothiazine drug, for 3 months to relieve dizziness. It is important to recognize this syndrome early and to treat immediately.
Subject(s)
Search on Google
Database: MEDLINE Main subject: Thiethylperazine / Neuroleptic Malignant Syndrome Limits: Female / Humans / Middle aged Language: He Year: 1990 Type: Article
Search on Google
Database: MEDLINE Main subject: Thiethylperazine / Neuroleptic Malignant Syndrome Limits: Female / Humans / Middle aged Language: He Year: 1990 Type: Article